Etlingera elatior Compounds as Anticancer Agents of Breast Cancer Through Inhibition of Progesterone Receptor: An In Silico Study

Putri Mahirah Afladhanti, Haidar Ali Hamzah, Muhammad Despriansyah Romadhan, Safa Nabila Putri, Ellen Callista Angelica, Theodorus Theodorus

Abstract


Breast cancer is the leading cause of cancer-related death in women globally. Progesterone receptor (PR) is known as the prime example of receptors amenable to targeted breast cancer drug therapy. Etlingera elatior is an herbal plant that has been renowned to have anticancer effect. This study aimed to identify the potential compounds derived from Etlingera elatior as anticancer agents of PR in breast cancer using molecular docking method. This study used fifteen compounds from Etlingera elatior along with lonaprisan as the comparative drug. The PR was downloaded from RCSB, whereas compounds and lonaprisan were from Pubchem. The drug-likeness test based on Lipinski’s rule of five was conducted using SwissADME. Toxicity analysis using admetSAR 2.0 was used to predict toxicological profile of the compounds. Compounds and lonaprisan were docked on PR using AutoDock tools 1.5.6 and AutoDock Vina 1.1.2. Molecular interactions were visualized by Discovery Studio v16. A total of nine compounds met the criteria as drugs based on drug-likeness and toxicity tests. All nine compounds except caffeic acid and vanillic acid had higher binding affinities on PR compared with lonaprisan. Ergosterol peroxide exhibited the highest binding affinity on PR with values of -9.8 kcal/mol. Moreover, ergosterol peroxide-PR interaction had thirteen hydrophobic bonds and a hydrogen bond with amino acid residues were found in the active site of PR. Most of the compounds found in Etlingera elatior have the potential to be anticancer agents of PR in breast cancer with ergosterol peroxide being the most potential compound. Further in vitro and in vivo research are needed.


Keywords: breast cancer, ergosterol peroxide, Etlingera elatior, progesterone receptor, in silico.


Full Text:

PDF

References


Aamir, M., Singh, V.K., Dubey, M.K., Meena, M., Kashyap, S.P., Katari, S.K., Upadhyay, R.S., et al., 2018, In silico prediction, characterization, molecular docking, and dynamic studies on fungal SDRs as novel targets for searching potential fungicides against fusarium wilt in tomato, Front Pharmacol, 9, 1038. CrossRef

Heery, M., Corbett, P. and Zelkowitz, R., 2018, Precautions for Patients Taking Tamoxifen, J Adv Pract Oncol, 9(1), 78-83. CrossRef

Anderson, B.O., Lipscomb, J., Murillo, R.H., and Thomas, D.B., 2015, Breast Cancer, Disease Control Priorities, 3, 45–68. CrossRef

Ansori, A.N.M., Susilo, R.J.K., and Hayaza, S., 2021, Biological Activity Investigation of Phytocomponents in Mangosteen (Garcinia mangostana L.): In Silico Study, Indian Journal of Forensic Medicine & Toxicology, 15(1), 847–851. CrossRef

Ardalan, M.-R., and Rafieian-Kopaei, M., 2013, Is the safety of herbal medicines for kidneys under question?, Journal of Nephropharmacology, 2(2), 11-12.

Arwansyah, Ambarsari, L., and Sumaryada, T.I., 2014, Simulasi Docking Senyawa Kurkumin dan Analognya Sebagai Inhibitor Reseptor Androgen pada Kanker Prostat, Current Biochemistry, 1(1), 11–19. CrossRef

Barrios, C.H., 2022, Global challenges in breast cancer detection and treatment, The Breast, 62(1), S3-S6. CrossRef

Benet, L.Z., Hosey, C.M., Ursu, O., and Oprea, T.I., 2016, BDDCS, the Rule of 5 and drugability, Advanced Drug Delivery Reviews, 101(1), 89–98. CrossRef

Daina, A., Michielin, O., and Zoete, V., 2017, SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules, Scientific Reports, 7, 42717. CrossRef

Harnis, A.P.D., Hasan, N.A.H.M., Janah, Y.K., Tsamara, C.A., and Fatchiyah, F., 2020, Virtual Inhibition Analysis of Bioactive Compound Brazilin (Caesalpinia sappan L.) Toward Progesterone Receptor or Lonaprisan in Breast Cancer Proliferation, Biotropika: Journal of Tropical Biology, 8(2), 62–70. CrossRef

Eberhardt, J., Santos-Martins, D., Tillack, A.F., and Forli, S., 2021, AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings, Journal of Chemical Information and Modeling, 61(8), 3891-3898. CrossRef

Farrar, M.C., and Jacobs, T.F., 2023, Tamoxifen, Encyclopedia of Toxicology: Third Edition, In StatPearls: StatPearls Publishing. CrossRef

Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., Ji, X., et al., 2018, Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis, Genes & Diseases, 5(2), 77–106. CrossRef

Ghasemzadeh, A., Jaafar, H.Z.E., Rahmat, A., and Ashkani, S., 2015, Secondary metabolites constituents and antioxidant, anticancer and antibacterial activities of Etlingera elatior (Jack) R.M.Sm grown in different locations of Malaysia, BMC Complement Altern Med., 15, 335. CrossRef

Głowacki, E.D., Irimia-Vladu, M., Bauer, S., and Sariciftci, N.S., 2013, Hydrogen-bonds in molecular solids–from biological systems to organic electronics, J Mater Chem B., 1, 3742–3753. CrossRef

Guan, L., Yang, H., Cai, Y., Sun, L., Di, P., Li, W., Liu, G., and Tang, Y., 2019, ADMET-score-a comprehensive scoring function for evaluation of chemical drug-likeness, Medchemcomm, 10, 148–157. CrossRef

Han, R., Gu, S., Zhang, Y., Luo, A., Jing, X., Zhao, L., Zhao, X., and Zhang, L., 2018, Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling, Scientific Reports, 8, 9575. CrossRef

Hassan, N.M., Alhossary, A.A., Mu, Y., and Kwoh, C-K., 2017, Protein-Ligand Blind Docking Using QuickVina-W with Inter-Process Spatio-Temporal Integration, Scientific Reports, 7, 1–13. CrossRef

He, L., Shi, W., Liu, X., Zhao, X., and Zhang, Z., 2018a, Anticancer Action and Mechanism of Ergosterol Peroxide from Paecilomyces cicadae Fermentation Broth, Int. J. Mol. Sci., 19(12), 3935. CrossRef

Ismail, S.Y., Uzairu, A., Sagagi, B., and Suleiman, M.S., 2018, In silico molecular docking and pharmacokinetic study of selected phytochemicals with estrogen and progesterone receptors as anticancer agent for breast cancer, , 5(3), 1337–1350. CrossRef

Jonat, W., Bachelot, T., Ruhstaller, T., Kuss, I., Reimann, U., and Robertson, J.F.R., 2013, Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer, Annals of oncology, 24(10), 2543–2548. CrossRef

Jin, J., Chen, B., Zhan, X., Zhou, Z., Liu, H., and Dong, Y., 2021, Network pharmacology and molecular docking study on the mechanism of colorectal cancer treatment using Xiao-Chai-Hu-Tang, PLoS One, 16(6), e0252508. CrossRef

Kemenkes RI, 2022, Kementerian Kesehatan Republik Indonesia [WWW Document].

Kulandaisamy, A., Lathi, V., ViswaPoorani, K., Yugandhar, K., and Gromiha, M.M., 2017a, Important amino acid residues involved in folding and binding of protein–protein complexes, International Journal of Biological Macromolecules, 94(Part A), 438–444. CrossRef

Kulandaisamy, A., Lathi, V., ViswaPoorani, K., Yugandhar, K., and Gromiha, M.M., 2017b, Important amino acid residues involved in folding and binding of protein–protein complexes, International Journal of Biological Macromolecules, 94(Part A), 438–444. CrossRef

Lachumy, S.J.T., Sasidharan, S., Sumathy, V., and Zuraini, Z., 2010, Pharmacological activity, phytochemical analysis and toxicity of methanol extract of Etlingera elatior (torch ginger) flowers, Asian Pac J Trop Med., 3(10), 769–774. CrossRef

Lenin, M., Ramakrishnan, E., and Sankaran, M., 2022, Structure-Based Molecular Docking Studies toward Exploring Phytoestrogen against Breast Cancer, Eurasian J Med Oncol., 6(2), 142-149. CrossRef

Lipinski, C.A., Lombardo, F., Dominy, B.W., and Feeney, P.J., 2012, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Advanced Drug Delivery Reviews, 64, 4–17. CrossRef

Macchiagodena, M., Pagliai, M., and Procacci, P., 2020, Inhibition of the Main Protease 3CL-pro of the Coronavirus Disease 19 via Structure-Based Ligand Design and Molecular Modeling, arXiv e-prints, 2002, 09937. CrossRef

Madhavi Sastry, G., Adsjigirey, M., Day, T., Annabhimoju, R., and Sherman, W., 2013, Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments, Journal of Computer-Aided Molecular Design, 27, 221–234. CrossRef

Mani, S., Swargiary, G., Gulati, S., Gupta, S., and Jindal, D., 2021, Molecular docking and ADMET studies to predict the anti-breast cancer effect of aloin by targeting estrogen and progesterone receptors, Materialstoday: Proceedings, 80(3), 2378-2384. CrossRef

Marques, A.M., de Paiva, R.A., da Fonseca, L.M., Capella, M.A.M., Guimarães, E.F., and Kaplan, M.A.C., 2013, Preliminary Anticancer Potency Evaluation and Phytochemical investigation of Methanol Extract of Piper claussenianum (Miq.) C. DC., J Appl Pharm Sci., 3(2), 013–018. CrossRef

Sumarni, W., Sudarmin, S., and Sumarti, S.S., 2019, The scientification of jamu: a study of Indonesian’s traditional medicine, J Phys Conf Ser., 1321, 032057.

Mohanty, P.S., Kumar, R., Pawar, N., Gogoi, C., Sharma, S., Pawar, H.S., Mohanty, K.K., et al., 2021, Structure based virtual screening, molecular docking and molecular dynamics simulation of drug like small molecules against cell cycle regulator enzyme FtsZ of Mycobacterium tuberculosis, Research Square, 1-17. CrossRef

Morris, G.M., Ruth, H., Lindstrom, W., Sanner, M.F., Belew, R.K., Goodsell, D.S., and Olson, A.J., 2009, Software News and Updates AutoDock4 and AutoDockTools4 : Automated Docking with Selective Receptor Flexibility, Journal of Computational Chemistry, 30(16), 2785–2791. CrossRef

Nisha, C.M., Kumar, Ashwini, Nair, P., Gupta, N., Silakari, C., Tripathi, T., and Kumar, A., 2016, Molecular docking and in silico ADMET study reveals acylguanidine 7a as a potential inhibitor of β-secretase, Advances in Bioinformatics, 2016, 9258578. CrossRef

Nurlaili, N., Maulida, A., Theresia, C., Sandika, F.A. and Hairah, U., 2022, Aplikasi Ekstrak Tanaman Kecombrang (Etlingera elatior) Sebagai Pengawet Alami pada Daging Ikan Nila (Oreochromis niloticus): Application of Kecombrang (Etlingera elatior) Plant Extract as a Natural Preservative in Tilapia (Oreochromis niloticus) Meat, Jurnal Sains dan Kesehatan (J. Sains Kes.), 4(2), 198–204. CrossRef

Pantsar, T., and Poso, A., 2018, Binding affinity via docking: Fact and fiction, Molecules, 23(8), 1899. CrossRef

Shah, A., Haider, G., Abro, N., Bhutto, S., Baqai, T.I., Akhtar, S., and Abbas, K., 2022, Correlation Between Age and Hormone Receptor Status in Women With Breast Cancer, Cureus., 14(1), 21652. CrossRef

Sohail, S.K., Sarfraz, R., Imran, M., Kamran, M., and Qamar, S., 2020, Estrogen and Progesterone Receptor Expression in Breast Carcinoma and Its Association with Clinicopathological Variables Among the Pakistani Population, Cureus., 12(8), e9751. CrossRef

Tan, W., Pan, M., Liu, H., Tian, H., Ye, Q., and Liu, H., 2017, Ergosterol peroxide inhibits ovarian cancer cell growth through multiple pathways, OncoTargets and Therapy, 10, 3467–3474. CrossRef

Tremont, A., Lu, J., and Cole, J.T., 2017, Endocrine Therapy for Early Breast Cancer: Updated Review, Ochsner J., 17(4), 405-411. CrossRef

Trott, O., and Olson, A.J., 2010, AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading, Journal of Computational Chemistry, 31(2), 455-461. CrossRef

Wagenfeld, A., Saunders, P.T.K., Whitaker, L., and Critchley, H.O.D., 2016, Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapies, Expert Opinion on Therapeutic Targets, 20(9), 1045–1054. CrossRef

Wahyuni, Diantini, A., Ghozali, M., and Sahidin, 2022, Etlingera Genus: Phytochemical Screening and Anticancer Activity, Jurnal Farmasi Sains dan Praktis (JFSP), 7(3), 343-355. CrossRef

World Health Organization, 2021, Breast cancer [WWW Document].

Yang, H., Lou, C., Sun, L., Li, J., Cai, Y., Wang, Z., Li, W., et al., 2019, AdmetSAR 2.0: Web-service for prediction and optimization of chemical ADMET properties, Bioinformatics, 35(6), 1067–1069. CrossRef

Zarezade, V., Abolghasemi, M., Rahim, F., Veisi, A., and Behbahani, M., 2018, In silico assessment of new progesterone receptor inhibitors using molecular dynamics: a new insight into breast cancer treatment, J Mol Model, 24, 337. CrossRef




DOI: http://dx.doi.org/10.14499/indonesianjcanchemoprev14iss2pp94-104

Copyright (c) 2023 Putri Mahirah Afladhanti, Haidar Ali Hamzah, Muhammad Despriansyah Romadhan, Safa Nabila Putri, Ellen Callista Angelica, Theodorus Theodorus

Indexed by:

                  

               

 

Indonesian Society for Cancer Chemoprevention